Xencor Inc - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and multiple XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein’s structure that result in new mechanisms of therapeutic action.
No news available
Have a question or want to work together? Fill out the form below and we’ll get back to you as soon as possible.
